A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes

Tsuyoshi Sakoda, Noriyuki Kasahara, Yasuo Hamamori, Larry Kedes

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

Human immunodeficiency virus (HIV, lentivirus) type-1 based vectors have a number of attractive features for gene therapy, including the ability to transduce non-dividing cells and long term transgene expression. We used a three-plasmid expression system to generate pseudotyped lentivirus-based vectors by transient transfection of human embryonic kidney 293T cells in the presence of sodium butyrate, which is known to activate the long terminal repeat-directed expression of HIV. Using this system we successfully generated versatile high titer lentivirus at titers of up to 2 x 10 8 transducing units/ml (TU/ml), and improved transduction efficiency in various cell types from seven to over twenty fold. We demonstrate its applicability of these vectors for the efficient transduction of non-dividing cells, including post mitotic beating rat cardiac myocytes and well-differentiated rat L6 myofibers. While both lentivirus-based and murine retrovirus-based vectors effectively transduced dividing cardiac fibroblasts and L6 muscle myoblasts in culture, lentivirus-based vectors also efficiently transduced cardiac myocytes and yielded titers of (6.3 ± 1.2) x 10 5 TU/ml; however murine retrovirus-based vectors showed low transduction efficiency with titers reaching only (8.9 ± 2.1) x 10 2 TU/ml. Furthermore, even 12 days after induction of differentiation of L6 myofibers, lentivirus-mediated transduction of β-galactosidase (β-Gal) at approximately 30-40%, of the maximum expression levels achieved in replicating myoblasts. In contrast, the expression of β-Gal following transduction of the myofibers by murine retrovirus-based vectors fell to less than 1%, of an already reduced level of transduction in undifferentiated confluent myoblasts. These results demonstrate that lentivirus-based vectors can efficiently transduce both well-differentiated cardiac myocytes and differentiated myofibers. This appears to be an efficient method and provides a new tool for research and therapy for cardiovascular diseases.

Original languageEnglish (US)
Pages (from-to)2037-2047
Number of pages11
JournalJournal of Molecular and Cellular Cardiology
Volume31
Issue number11
DOIs
StatePublished - Nov 1999
Externally publishedYes

Fingerprint

Lentivirus
Cardiac Myocytes
Myoblasts
Retroviridae
HIV
Galactosidases
Butyric Acid
Terminal Repeat Sequences
HEK293 Cells
Transgenes
Genetic Therapy
Transfection
HIV-1
Plasmids
Cardiovascular Diseases
Fibroblasts
Kidney
Muscles
Research

Keywords

  • Cardiac myocyte
  • Gene therapy
  • L6 cell
  • Lentivirus
  • Retrovirus
  • Sodium butyrate
  • Vesicular stomatitis virus

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes. / Sakoda, Tsuyoshi; Kasahara, Noriyuki; Hamamori, Yasuo; Kedes, Larry.

In: Journal of Molecular and Cellular Cardiology, Vol. 31, No. 11, 11.1999, p. 2037-2047.

Research output: Contribution to journalArticle

@article{8c0ae77d23c945d9863239c798003f9e,
title = "A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes",
abstract = "Human immunodeficiency virus (HIV, lentivirus) type-1 based vectors have a number of attractive features for gene therapy, including the ability to transduce non-dividing cells and long term transgene expression. We used a three-plasmid expression system to generate pseudotyped lentivirus-based vectors by transient transfection of human embryonic kidney 293T cells in the presence of sodium butyrate, which is known to activate the long terminal repeat-directed expression of HIV. Using this system we successfully generated versatile high titer lentivirus at titers of up to 2 x 10 8 transducing units/ml (TU/ml), and improved transduction efficiency in various cell types from seven to over twenty fold. We demonstrate its applicability of these vectors for the efficient transduction of non-dividing cells, including post mitotic beating rat cardiac myocytes and well-differentiated rat L6 myofibers. While both lentivirus-based and murine retrovirus-based vectors effectively transduced dividing cardiac fibroblasts and L6 muscle myoblasts in culture, lentivirus-based vectors also efficiently transduced cardiac myocytes and yielded titers of (6.3 ± 1.2) x 10 5 TU/ml; however murine retrovirus-based vectors showed low transduction efficiency with titers reaching only (8.9 ± 2.1) x 10 2 TU/ml. Furthermore, even 12 days after induction of differentiation of L6 myofibers, lentivirus-mediated transduction of β-galactosidase (β-Gal) at approximately 30-40{\%}, of the maximum expression levels achieved in replicating myoblasts. In contrast, the expression of β-Gal following transduction of the myofibers by murine retrovirus-based vectors fell to less than 1{\%}, of an already reduced level of transduction in undifferentiated confluent myoblasts. These results demonstrate that lentivirus-based vectors can efficiently transduce both well-differentiated cardiac myocytes and differentiated myofibers. This appears to be an efficient method and provides a new tool for research and therapy for cardiovascular diseases.",
keywords = "Cardiac myocyte, Gene therapy, L6 cell, Lentivirus, Retrovirus, Sodium butyrate, Vesicular stomatitis virus",
author = "Tsuyoshi Sakoda and Noriyuki Kasahara and Yasuo Hamamori and Larry Kedes",
year = "1999",
month = "11",
doi = "10.1006/jmcc.1999.1035",
language = "English (US)",
volume = "31",
pages = "2037--2047",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "11",

}

TY - JOUR

T1 - A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes

AU - Sakoda, Tsuyoshi

AU - Kasahara, Noriyuki

AU - Hamamori, Yasuo

AU - Kedes, Larry

PY - 1999/11

Y1 - 1999/11

N2 - Human immunodeficiency virus (HIV, lentivirus) type-1 based vectors have a number of attractive features for gene therapy, including the ability to transduce non-dividing cells and long term transgene expression. We used a three-plasmid expression system to generate pseudotyped lentivirus-based vectors by transient transfection of human embryonic kidney 293T cells in the presence of sodium butyrate, which is known to activate the long terminal repeat-directed expression of HIV. Using this system we successfully generated versatile high titer lentivirus at titers of up to 2 x 10 8 transducing units/ml (TU/ml), and improved transduction efficiency in various cell types from seven to over twenty fold. We demonstrate its applicability of these vectors for the efficient transduction of non-dividing cells, including post mitotic beating rat cardiac myocytes and well-differentiated rat L6 myofibers. While both lentivirus-based and murine retrovirus-based vectors effectively transduced dividing cardiac fibroblasts and L6 muscle myoblasts in culture, lentivirus-based vectors also efficiently transduced cardiac myocytes and yielded titers of (6.3 ± 1.2) x 10 5 TU/ml; however murine retrovirus-based vectors showed low transduction efficiency with titers reaching only (8.9 ± 2.1) x 10 2 TU/ml. Furthermore, even 12 days after induction of differentiation of L6 myofibers, lentivirus-mediated transduction of β-galactosidase (β-Gal) at approximately 30-40%, of the maximum expression levels achieved in replicating myoblasts. In contrast, the expression of β-Gal following transduction of the myofibers by murine retrovirus-based vectors fell to less than 1%, of an already reduced level of transduction in undifferentiated confluent myoblasts. These results demonstrate that lentivirus-based vectors can efficiently transduce both well-differentiated cardiac myocytes and differentiated myofibers. This appears to be an efficient method and provides a new tool for research and therapy for cardiovascular diseases.

AB - Human immunodeficiency virus (HIV, lentivirus) type-1 based vectors have a number of attractive features for gene therapy, including the ability to transduce non-dividing cells and long term transgene expression. We used a three-plasmid expression system to generate pseudotyped lentivirus-based vectors by transient transfection of human embryonic kidney 293T cells in the presence of sodium butyrate, which is known to activate the long terminal repeat-directed expression of HIV. Using this system we successfully generated versatile high titer lentivirus at titers of up to 2 x 10 8 transducing units/ml (TU/ml), and improved transduction efficiency in various cell types from seven to over twenty fold. We demonstrate its applicability of these vectors for the efficient transduction of non-dividing cells, including post mitotic beating rat cardiac myocytes and well-differentiated rat L6 myofibers. While both lentivirus-based and murine retrovirus-based vectors effectively transduced dividing cardiac fibroblasts and L6 muscle myoblasts in culture, lentivirus-based vectors also efficiently transduced cardiac myocytes and yielded titers of (6.3 ± 1.2) x 10 5 TU/ml; however murine retrovirus-based vectors showed low transduction efficiency with titers reaching only (8.9 ± 2.1) x 10 2 TU/ml. Furthermore, even 12 days after induction of differentiation of L6 myofibers, lentivirus-mediated transduction of β-galactosidase (β-Gal) at approximately 30-40%, of the maximum expression levels achieved in replicating myoblasts. In contrast, the expression of β-Gal following transduction of the myofibers by murine retrovirus-based vectors fell to less than 1%, of an already reduced level of transduction in undifferentiated confluent myoblasts. These results demonstrate that lentivirus-based vectors can efficiently transduce both well-differentiated cardiac myocytes and differentiated myofibers. This appears to be an efficient method and provides a new tool for research and therapy for cardiovascular diseases.

KW - Cardiac myocyte

KW - Gene therapy

KW - L6 cell

KW - Lentivirus

KW - Retrovirus

KW - Sodium butyrate

KW - Vesicular stomatitis virus

UR - http://www.scopus.com/inward/record.url?scp=0032698781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032698781&partnerID=8YFLogxK

U2 - 10.1006/jmcc.1999.1035

DO - 10.1006/jmcc.1999.1035

M3 - Article

C2 - 10591030

AN - SCOPUS:0032698781

VL - 31

SP - 2037

EP - 2047

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 11

ER -